Amrecibart for thrombosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 24 Feb 2026: Trial registered, NCT07430956
  2. 3 Apr 2026: Trial started, NCT07430956

The trials

NCT07175428: Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

State
Under way
Phase
Phase 2
People
1,200 planned
Started
20 Oct 2025
Primary completion
9 Feb 2027
Arms
REGN9933
Results
None posted
  1. 16 Sep 2025: Trial registered
  2. 20 Oct 2025: Trial started

NCT07430956: Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

State
Under way
Phase
Phase 3
People
2,628 planned
Started
3 Apr 2026
Primary completion
28 Mar 2029
Arms
REGN9933
Results
None posted
  1. 24 Feb 2026: Trial registered
  2. 3 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.